A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors

Clinical trial NCT06208124 · COMPLETED

Trial details

NCT number: NCT06208124
Sponsor: Immuneering Corporation
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor (Phase 1)Pancreas Adenocarcinoma Non-small Cell Lung Cancer Malignant Melanoma (Cutaneous)

Start date: 2024-02-27
Primary completion: 2025-04-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.